The increased expression of both proteins can be associated with an enhanced insulin sensitivity and the capability to prevent the impaired muscle glucose metabolism that is characteristic of diabetes mellitus and other metabolic syndromes. The gene discussed is INS; the disease is metabolic syndrome.